title: 5-alpha Reductase inhibitors in prostate cancer: from clinical trials to clinical practice.
authors.forename: Behfar
authors.initials: B
authors.lastname: Ehdaie
authors.forename: Karim A
authors.initials: KA
authors.lastname: Touijer
mesh_terms: D058891:5-alpha Reductase Inhibitors / Q000008:administration & dosage*; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage*; D001378:Azasteroids / Q000008:administration & dosage*; D000068538:Dutasteride; D006801:Humans; D007610:Kallikreins / Q000097:blood*; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood*; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000601:surgery*
chemical_list: D058891:5-alpha Reductase Inhibitors; D018931:Antineoplastic Agents, Hormonal; D001378:Azasteroids; C549870:KLK3 protein, human; D007610:Kallikreins; D017430:Prostate-Specific Antigen; D000068538:Dutasteride